Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESTORE: Resveratrol in older people with PAD
NCT02246660Completed
- Sponsor
- Northwestern University
- Start
- Jan 2015
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of resveratrol in Peripheral Arterial Disease (PAD) (3 arms), sponsored by Northwestern University. Primary endpoint: 6-Minute Walk Distance at 6 months. Started Jan 2015; status: completed.
02
Drugs
resveratrol
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT02246660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02246660.